Expenditure | 2010–2011 | 2011–2012 | 2012–2013 | 2013–2014 |
---|---|---|---|---|
Orphan drugs (all) | 23.52 % | 20.16 % | −30.01 % | 23.16 % |
Orphan drugs (excl. Glivec) | 47.73 % | 70.67 % | 23.00 % | 23.16 % |
Total pharmaceutical market | 4.88 % | 1.82 % | 4.10 % | 2.75 % |
Total drug reimbursement budget | 11.61 % | −1.01 % | 0.32 % | 4.21 % |